Increasing Utilization and Excellent Early Outcomes Following Liver Transplant of HCV Viremic Donors into HCV Positive and Negative Recipients

被引：0

作者：

Paul, Sonali ^{[1
]}

Cotter, Thomas ^{[2
]}

Sandikci, Burhaneddin ^{[3
]}

Couri, Thomas ^{[4
]}

Little, Ester C. ^{[5
]}

Sundaram, Vinay ^{[6
]}

Bodzin, Adam ^{[7
]}

Charlton, Michael R. ^{[8
]}

机构：

[1] Univ Chicago, Div Gastroenterol & Hepatol, Chicago, IL 60637 USA

[2] Univ Chicago Med, Gastroenterol Hepatol & Nutr, Chicago, IL USA

[3] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA

[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[5] Banner Good Samaritan Med Ctr, Phoenix, AZ USA

[6] Cedars Sinai Med Ctr, Gastroenterol, Los Angeles, CA 90048 USA

[7] Univ Chicago, Transplant Surg, Chicago, IL 60637 USA

[8] Univ Chicago, Chicago, IL 60637 USA

来源：

HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

249

引用

页码：154A / 154A

页数：1

共 50 条

[21] Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin
Kapila, Nikhil
Flocco, Gianina
Al Khalloufi, Kawtar
Zervos, Xaralambos B.
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (03) : 407 - 409
[22] Viral Kinetics of De Novo HCV Infection and Response to Antiviral Therapy in Liver and Kidney Transplant Recipients Receiving HCV-Viremic Donors
Terrault, N.
Burton, J.
Verna, E.
Mobley, C.
Victor, D.
Trotter, J.
Niemann, C.
Rubin, R.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 828 - 828
[23] Transplantation of HCV Positive Kidneys Confers Excellent Outcomes for HCV Infected and Uninfected Recipients
Torabi, J.
Muhdi, N.
Montal, A.
Melvin, J.
Miura, Y.
Rocca, J. P.
Ajaimy, M.
Lirano, L.
Azzi, Y.
Pynadath, C.
Alani, O.
Akalin, E.
Greenstein, S.
Kinkhabwala, M.
Graham, J. A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 882 - 882
[24] Utilization of Hepatitis C Virus (HCV)-Viremic Organs for HCV Negative Recipients: Is Practice Speeding Past the Evidence?
Verna, Elizabeth C.
Tsapepas, Demetra
Emond, Jean C.
Brown, Robert S.
Mohan, Sumit
HEPATOLOGY, 2020, 71 (01) : 4 - 7
[25] Prospective multicenter study of sofosbuvir-velpatasvir (SOF/VEL) in hepatitis C virus (HCV) negative liver (LT) and kidney transplant (KT) recipients receiving HCV viremic donors
Rubin, Raymond
Victor, David
Burton, James
Verna, Elizabeth
Trotter, James F.
Niemann, Claus
Mobley, Constance
Terrault, Norah
JOURNAL OF HEPATOLOGY, 2020, 73 : S276 - S276
[26] SUCCESSFUL EARLY SOFOSBUVIR-BASED ANTIVIRAL TREATMENT AFTER TRANSPLANTATION OF KIDNEYS FROM HCV-VIREMIC DONORS INTO HCV-NEGATIVE RECIPIENTS
Friebus-Kardash, Justa
Gaeckler, Anja
Kribben, Andreas
Witzke, Oliver
Wedemeyer, Heiner
Treckmann, Juergen
Herzer, Kerstin
Eisenberger, Ute
TRANSPLANT INTERNATIONAL, 2019, 32 : 203 - 203
[27] HISTOLOGICAL AND SVR DATA ON HCV plus GRAFT TO HCV NEGATIVE LIVER TRANSPLANT RECIPIENTS
Nair, Satheesh
Maliakkal, Benedict J.
Handley, Charlotte
Snyder, Heather S.
Helmick, Ryan
Roberts, Jacqueline
Eason, James D.
HEPATOLOGY, 2019, 70 : 708A - 709A
[28] Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients
Friebus-Kardash, Justa
Gaeckler, Anja
Kribben, Andreas
Witzke, Oliver
Wedemeyer, Heiner
Treckmann, Juergen
Herzer, Kerstin
Eisenberger, Ute
TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (05)
[29] Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients
Wu, Ying
Ahmed, Aijaz
Kamal, Ahmad
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (02) : 574 - 578
[30] Donor Diabetes Mellitus Is an Independent Risk Factor for Graft Loss in HCV Positive but Not HCV Negative Liver Transplant Recipients
Ying Wu
Aijaz Ahmed
Ahmad Kamal
Digestive Diseases and Sciences, 2013, 58 : 574 - 578

← 1 2 3 4 5 →